High prevalence of high-risk HPV genotypes other than 16 and 18 in cervical cancers of Curaçao: implications for choice of prophylactic HPV vaccine: implications for choice of prophylactic HPV vaccine

Desiree J. Hooi, Birgit I. Lissenberg-Witte, Maurits N. C. de Koning, Herbert M. Pinedo, Gemma G. Kenter, Chris Jlm Meijer, Wim G. Quint

Research output: Contribution to journalArticleAcademicpeer-review

11 Citations (Scopus)


BACKGROUND: Curaçao is a Dutch-Caribbean Island located in a high-risk area for cervical cancer.Prior to introduction of a prophylactic human papillomavirus (HPV) vaccine, knowledge of the prevalence of high-risk HPV vaccine genotypes (HPV16, 18, 31, 33, 45, 52 and 58) in cervical (pre)cancer is required.
Original languageEnglish
Pages (from-to)263-267
JournalSexually transmitted infections
Issue number4
Early online date11 Oct 2017
Publication statusPublished - 2018


  • Journal Article

Cite this